Press Releases on September 17, 2018 - EIN Presswire - Press Release Distribution Service

Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Siklos, hydroxycarbamide, Anemia, Sickle Cell, Date of authorisation: 29/...

Siklos is used in adults, adolescents and children over two years of age who have sickle-cell syndrome, a genetic disease where the red blood cells become rigid and sticky, and change from being disc-shaped to being crescent-shaped (like a sickle). It is …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:15 GMT

Orphan designation: Cannabidivarin, Treatment of Rett syndrome, 16/10/2017, Positive

Rett syndrome is a genetic disease characterised by intellectual disability as well as by loss of speech and regression of acquired skills between 6 and 18 months of age. Other symptoms include difficulty breathing, irregular heartbeat, a gradual loss of …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:15 GMT

Opinion/decision on a Paediatric investigation plan (PIP): Heplisav B,Hepatitis B (rDNA) surface antigen adjuvanted, decision type:...

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Duavive, oestrogens conjugated,bazedoxifene, Postmenopause, Date of ...

Duavive was compared with placebo (a dummy treatment) in two main studies in 996 women who have been through the menopause, investigating the effects on either hot flushes or vulvovaginal atrophy (dryness, irritation and soreness around the genital area …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Duavive, oestrogens conjugated,bazedoxifene, Postmenopause, Date of ...

Duavive was compared with placebo (a dummy treatment) in two main studies in 996 women who have been through the menopause, investigating the effects on either hot flushes or vulvovaginal atrophy (dryness, irritation and soreness around the genital area …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Carcinoma, Non-Small-Cell Lung;Pancreatic Neoplasms, ...

Non-small cell lung cancer (NSCLC) Tarceva is also indicated for switch maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with EGFR activating mutations and stable disease after first-line chemotherapy. …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Carcinoma, Non-Small-Cell Lung;Pancreatic Neoplasms, ...

Non-small cell lung cancer (NSCLC) Tarceva is also indicated for switch maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with EGFR activating mutations and stable disease after first-line chemotherapy. …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Hypertension, Date of authorisation: 26/08/1997, ...

Karvea was originally studied in 11 trials for its effects on blood pressure. Karvea was compared with placebo (a dummy treatment) in 712 patients and with other medicines for hypertension (atenolol, enalapril or amlodipine) in 823 patients. Its use in …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:15 GMT

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Hypertension, Date of authorisation: 26/08/1997, ...

Karvea was originally studied in 11 trials for its effects on blood pressure. Karvea was compared with placebo (a dummy treatment) in 712 patients and with other medicines for hypertension (atenolol, enalapril or amlodipine) in 823 patients. Its use in …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:15 GMT

What’s Up Moms Co-Founders Share Their Story At M2Moms® – The Marketing to Moms Conference

How & Why They Created and Built The #1 Parenting Channel on YouTube NEW YORK, NEW YORK, USA, September 17, 2018 /⁨EINPresswire.com⁩/ -- Co-Founders Elle Walker & Meg Reskinoff will tell the story of What’s Up Moms success, at the 14th Annual …

Distribution channels: Consumer Goods, Food & Beverage Industry ...

Published on September 17, 2018 - 12:15 GMT

New York Mortgage Trust Declares Third Quarter 2018 Common Stock Dividend of $0.20 Per Share, and Preferred Stock Dividends

NEW YORK, Sept. 17, 2018 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today that its Board of Directors (the “Board”) declared a regular quarterly cash dividend of $0.20 per share on shares of its common stock …

Distribution channels: Banking, Finance & Investment Industry ...

Published on September 17, 2018 - 12:15 GMT

Opinion/decision on a Paediatric investigation plan (PIP): binimetinib, decision type: , therapeutic area: , PIP number: P/0488/...

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:14 GMT

Tadalafil product-specific bioequivalence guidance

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:14 GMT

IIROC Trading Halt / Suspension de la negociation par l'OCRCVM - SKE

VANCOUVER, British Columbia, Sept. 17, 2018 (GLOBE NEWSWIRE) -- The following issues have been halted by IIROC / L'OCRCVM a suspendu la negociation des titres suivants: Company / Société : Skeena Resources Ltd. TSX-Venture Symbol / Symbole à la Bourse …

Distribution channels: Banking, Finance & Investment Industry

Published on September 17, 2018 - 12:14 GMT

Healthcare Professionals' Working Party meetings

For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:14 GMT

Human medicines European public assessment report (EPAR): Abilify Maintena, aripiprazole, Schizophrenia, Date of authorisation: 14/...

Abilify Maintena is an antipsychotic medicine that contains the active substance aripiprazole. It is used for the maintenance treatment of schizophrenia in adults whose disease has already been stabilised with aripiprazole taken by mouth. Schizophrenia is …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:14 GMT

Human medicines European public assessment report (EPAR): Abilify Maintena, aripiprazole, Schizophrenia, Date of authorisation: 14/...

Abilify Maintena is an antipsychotic medicine that contains the active substance aripiprazole. It is used for the maintenance treatment of schizophrenia in adults whose disease has already been stabilised with aripiprazole taken by mouth. Schizophrenia is …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:14 GMT

Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos), daunorubicin,cytarabine, ...

The most common side effects with Vyxeos liposomal (which may affect more than 1 in 5 people) are hypersensitivity (allergic reactions, especially rash), febrile neutropenia (low white cell counts with fever), oedema (swelling), diarrhoea, colitis ( …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:14 GMT

Human medicines European public assessment report (EPAR): Vyxeos liposomal (previously known as Vyxeos), daunorubicin,cytarabine, ...

The most common side effects with Vyxeos liposomal (which may affect more than 1 in 5 people) are hypersensitivity (allergic reactions, especially rash), febrile neutropenia (low white cell counts with fever), oedema (swelling), diarrhoea, colitis ( …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 17, 2018 - 12:14 GMT

Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Dermatitis, Atopic;Prurigo;Esophageal Diseases;...

Atopic dermatitis Dupixent was more effective than placebo (a dummy treatment) at reducing the extent and severity of atopic dermatitis in 3 main studies in adults with moderate to severe disease. In the first study, which involved 740 patients, …

Distribution channels: Healthcare & Pharmaceuticals Industry